Recommendations for clinical practice. Management of uterine fibroma with medical treatment;Traitement medical des fibromes uterins

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 28, Issue 7, 1999, Pages 729-731

  Boubli, L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; GONADORELIN AGONIST; MIFEPRISTONE; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

ARTICLE; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL PROTOCOL; DRUG INDICATION; HUMAN; UTERUS MYOMA; FEMALE; LEIOMYOMA; PATHOLOGY; REVIEW; UTERUS CANCER;

FEMALE; HUMANS; LEIOMYOMA; MEDROXYPROGESTERONE 17-ACETATE; PROGESTINS; UTERINE NEOPLASMS;

EID: 0033391472     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Andersen J. Factors in fibroid growth. Baillieres. Clin Obstet Gynaecol 1998; 12 (2): 225-43.
2. Audebert AJ, Denis C. Utilisation de la promégestone dans le traitement des fibromyomes compliqués de ménométrorragies. Bilan d'une étude multicentrique. Gynécologie 1989 ; 40 (suppl. 2) : 23-6.
3. Chrapusta S, Konopka B, Paszko Z, Sieinski W, Szamborski J. Mmunoreactive and estrogen-binding estrogen receptors, and progestin receptor I evels in uterine leiomyomata and their parental myometrium. Eur J Gynaecol Oncol 1990; 11 (4): 275-81.
4. Coutinho EM, Goncalves MT. Long-term treatment of leiomyomas with gestrinone. Fertil Steril 1989; 51 (6): 939-46.
5. Friedman AJ, Daly M, Juneau-Norcross M, Gleason R, Rein MS, LeBoff M Hum Reprod1994; 9 (9): 1618-2.
6. Harrison-Woolrych M, Robinson R Fibroid growth in response to high-dose progestogen. Fertil Steril 1995; 64 (1): 191-2.
7. Marugo M, Centonze M, Bemasconi D, Fazzuoli L, Berta S, Giordano G. Estrogen and progesterone receptors in uterine leiomyomas. Acta Obstet Gynecol Scand 1989; 68 (8): 731-5.
8. Murphy AA, Morales AJ, Kettel LM, Yen SS. Regression of uterine leiomyomata to the antiprogesterone RU486: doseresponse effect. Fertil Steril 1995; 64 (1): 187-90.
9. Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995; 172 (1 Pt 1): 14-8.
10. Reinsch RC, Murphy AA, Morales AJ, Yen SS. The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study. Am J Obstet Gynecol 1994; 170 (6): 1623-7; discussion 1627-8.
11. Scialli AR, Jestila KJ. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri. Fertil Steril 1995; 64 (2): 313-20.
12. Tiltman AJ. The effect of progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Pathol 1985; 4 (2): 89-96.
13. ViJ U, Murugesan K, Laumas KR, Farooq A. Progestin and antiprogestin interactions with progesterone receptors in human my omas. Int J Gynaecol Obstet 1990; 31 (4): 347-53.